Keywords: novartis, ibs, treatment, cleared, canada, brazil, been
Novartis' IBS treatment cleared in Canada, Brazil
Article | 25 March 2002
Novartis has been granted two additional marketing approvals for itsirritable bowel syndrome treatment Zelmac/Zelnorm (tegaserod). The drug, which is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
